| HDAC inhibitors as novel anti-cancer therapeutics C De Souza, B P Chatterji Recent patents on anti-cancer drug discovery 10 (2), 145-162, 2015 | 137 | 2015 |
| Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma H Chen, K Gotimer, C De Souza, CG Tepper, AN Karnezis, ... Gynecologic oncology 157 (3), 783-792, 2020 | 52 | 2020 |
| Genome-scale CRISPR knockout screen identifies TIGAR as a modifier of PARP inhibitor sensitivity P Fang, C De Souza, K Minn, J Chien Communications biology 2 (1), 335, 2019 | 45 | 2019 |
| Olaparib-induced adaptive response is disrupted by FOXM1 targeting that enhances sensitivity to PARP inhibition P Fang, JA Madden, L Neums, RK Moulder, ML Forrest, J Chien Molecular Cancer Research 16 (6), 961-973, 2018 | 37 | 2018 |
| The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) N Batra, C De Souza, J Batra, AG Raetz, AM Yu International journal of molecular sciences 21 (17), 6412, 2020 | 36 | 2020 |
| Precise oral delivery systems for probiotics: A review Y Luo, C De Souza, M Ramachandran, S Wang, H Yi, Z Ma, L Zhang, ... Journal of Controlled Release 352, 371-384, 2022 | 28 | 2022 |
| ACE inhibitory peptide KYIPIQ derived from yak milk casein induces nitric oxide production in HUVECs and diffuses via a transcellular mechanism in Caco-2 monolayers K Lin, Z Ma, M Ramachandran, C De Souza, X Han, L Zhang Process Biochemistry 99, 103-111, 2020 | 28 | 2020 |
| Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy Z Ma, J Li, K Lin, M Ramachandran, D Zhang, M Showalter, C De Souza, ... Nature communications 11 (1), 4615, 2020 | 26 | 2020 |
| Targeting epigenetic modifiers of tumor plasticity and cancer stem cell behavior VE Kumar, R Nambiar, C De Souza, A Nguyen, J Chien, KS Lam Cells 11 (9), 1403, 2022 | 21 | 2022 |
| Innate immune cell activation causes lung fibrosis in a humanized model of long COVID L Cui, Z Fang, CM De Souza, T Lerbs, Y Guan, I Li, V Charu, SY Chen, ... Proceedings of the National Academy of Sciences 120 (10), e2217199120, 2023 | 20 | 2023 |
| Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer JC Cristabelle De Souza, Jill Madden , Devin C Koestler , Dennis Minn ... Journal of the National Cancer Institute, 2021 | 19* | 2021 |
| Nanomaterials as potential transporters of HDAC inhibitors C De Souza, Z Ma, AR Lindstrom, BP Chatterji Medicine in Drug Discovery 6, 100040, 2020 | 14 | 2020 |
| Glycyrrhiza polysaccharides can improve and prolong the response of chickens to the Newcastle disease vaccine Y Wu, N Li, T Zhang, Y Che, K Duan, Y Wang, H Zhou, X Wan, H Lei, ... Poultry science 101 (1), 101549, 2022 | 13 | 2022 |
| A pH‐Driven Small‐Molecule Nanotransformer Hijacks Lysosomes and Overcomes Autophagy‐Induced Resistance in Cancer Z Ma, K Lin, M Tang, M Ramachandran, R Qiu, J Li, LN Solano, Y Huang, ... Angewandte Chemie International Edition 61 (35), e202204567, 2022 | 11 | 2022 |
| The Masquelet technique combined with the muscle flap for use in emergency management of acute Gustilo type III trauma of the lower limb with segmental bone loss: Case series L Deng, A Yu, B Qi, J Lei, C De Souza, S Zhu, L Yu International Journal of Surgery 81, 85-93, 2020 | 10 | 2020 |
| Long non-coding RNA signatures as predictors of prognosis in thyroid cancer: a narrative review H Zhao, C De Souza, VE Kumar, R Nambiar, D Hao, X Zhu, Y Luo, S Liu, ... Annals of translational medicine 9 (4), 2021 | 9 | 2021 |
| Immunomodulatory and antioxidant effects of Glycyrrhiza uralensis polysaccharide in Lohmann Brown chickens H Zhou, C Dai, X Cui, T Zhang, Y Che, K Duan, L Yi, AD Nguyen, N Li, ... Frontiers in Veterinary Science 9, 959449, 2022 | 8 | 2022 |
| The P72R polymorphism in R248Q/W p53 mutants modifies the mutant effect on epithelial to mesenchymal transition phenotype and cell invasion via CXCL1 expression C De Souza, JA Madden, D Minn, VE Kumar, DJ Montoya, R Nambiar, ... International Journal of Molecular Sciences 21 (21), 8025, 2020 | 8 | 2020 |
| Heterozygous mutations in valosin-containing protein (VCP) and resistance to VCP inhibitors P Bastola, R Bilkis, C De Souza, K Minn, J Chien Scientific reports 9 (1), 11002, 2019 | 7 | 2019 |
| P Chatterji B: HDAC inhibitors as novel anti-cancer therapeutics C De Souza Recent Patents on Anti-cancer Drug Discovery 10 (2), 145-162, 2015 | 7 | 2015 |
